Scavenger receptor (immunology)
Scavenger receptors are a large and diverse superfamily of cell surface receptors. Its properties were first recorded in 1970 by Drs. Brown and Goldstein, with the defining property being the ability to bind and remove modified low density lipoproteins. Today scavenger receptors are known to be involved in a wide range of processes, such as: homeostasis, apoptosis, inflammatory diseases and pathogen clearance. Scavenger receptors are mainly found on myeloid cells and other cells that bind to numerous ligands, primarily endogenous and modified host-molecules together with pathogen-associated molecular patterns, and remove them. The Kupffer cells in the liver are particularly rich in scavenger receptors, includes SR-A I, SR-A II, and MARCO.
Function
The scavenger receptor superfamily is defined by its ability to recognize and bind a broad range of common ligands. These ligands include: polyanionic ligands including lipoproteins, apoptotic cells, cholesterol ester, phospholipids, proteoglycans, ferritin, and carbohydrates. This broad recognition range allows scavenger receptors to play an important role in homeostasis and the combating of diseases. This is accomplished via the recognition of various PAMP's and DAMP's, which leads to the removal or scavenging of pathogens with the recognition of PAMP's and the removal of apoptotic cells, self reactive antigens and the products of oxidative stress.In atherosclerotic lesions, macrophages that express scavenger receptors on their plasma membrane take up the oxidized LDL deposited in the blood vessel wall aggressively, and develop into foam cells. Likewise, they secrete various inflammatory cytokines and accelerate the development of atherosclerosis.
Types
Scavenger receptors are incredibly diverse and therefore they organized into many different classes, starting at A and continuing to L. This organization is based on their structural properties. Due to the diversity and ongoing research into scavenger receptors, the receptors lack an accepted nomenclature and they have been described under different names. In 2014 a new nomenclature has been proposed which has been used by some researchers, although no official recognition has been given.- Class A is mainly expressed in the macrophage, and a protein whose molecular weight is about 80 kDa makes a trimer; it is composed of 1) cytosol domain, 2) transmembrane domain, 3) spacer domain, 4) alpha-helical coiled-coil domain, 5) collagen-like domain, and 6) cysteine-rich domain.
- Class B has two transmembrane regions.
- Class C is a transmembrane protein whose N-terminus is located extracellularly.
Class A
Members include:Scavenger receptors type 1 is a trimer with a molecular weight of about 220-250 kDa. It preferentially bind modified LDL, either acylated or oxidized. Other ligands include: binds to β-amyloid, heat shock proteins, surface molecules of Gram-positive and Gram-negative bacteria, hepatitis C virus.
SR-A1 can be alternatively spliced which contains a reduced C-terminus, it is contained within the Endoplasmatic Reticulum and just like the unspliced version has a strong affinity for polyanionic ligand binding.
- SCARA1 or MSR1: SR-A1 besides macrophages they can also be found on the smooth vascular muscle cells and endothelial tissues, oxidative stress enhances their presence on the endothelium.
- SCARA2 or MARCO: SR-A6, only found on macrophages in the peritoneum, lymph nodes, liver and specific zones of the spleen. Bacteria and lipopolysaccharide produced by bacteria stimulate its expression, SR-A6 is unable to connect with modiefied LDL.
- SCARA3, MSRL1 or APC7: SR-A3 plays an significant role in the protection against reactive oxygen species.
- SCARA4 or COLEC12: SR-A4 acts as a receptor for the detection, engulfment and destruction of oxidatively modified LDL for vascular endothelial cells.
- SCARA5 or TESR: SR-A5 located in a diverse set of tissues, such as: lung placenta, intestine, heart and epithelial cells, and has a high affinity for bacteria but not for modified LDL.
Class B
Members include:
- SCARB1 or CD36L1: SR-B1 can interact not only with oxidized LDL but also with normal LDL and high-density lipoproteins. And plays an important role in their transportation into the cells. Recent studies have indicated that SR-BI is likely to be the major receptor involved in HDL metabolism in mice and humans. Besides LDL and HDL SR-B1 binds to viruses, bacteria. SR-B1 is located on the hepatocytes, steroidogenic cells, arterial wall and macrophages.Mutations in SR-B1 have a negative effect on fertility, the innate immune response and leads to an increase in antherosclerosis.
- SCARB2
- SCARB3 or CD36: SR-B2 has been thought to be implicated in cell adhesion, developmement of blood vessels, in the phagocytosis of apoptotic cells, and in the metabolism of long-chain fatty acids. Furtheremore it has been shown that CD36 is heavily involved with macrophage migration and signalling, together with protecting the hoast against, bacteria, fungi and malaria parasites. In experimental mice models of atherosclerosis in which the gene for CD36 has been deleted, the mice have a greatly reduced number of atherosclerotic lesions. CD36 can be found in many different cells, for example: insulin-responsive cells, hematopoietic cells like platelets, monocytes, and macrophages, endothelial cells, and specialized epithelial cells in the breast and eye.
Other
- CD68 and its mouse homologue, macrosialin, has a unique N-terminal mucin-like domain.
- Mucin is a viscous substance that is composed of a protein and polysaccharides binding it. A Drosophila class C scavenger receptor also has a mucin-like structure.
- Lectin-like oxidized LDL receptor-1 was isolated from an aortic endothelial cell, and recently it has been discovered in macrophages and vascular smooth muscle cells in artery vessels. The expression of LOX-1 is inducted by inflammatory stimuli, so LOX-1 is thought to be involved in the development of atherosclerotic lesions.